Market Overview

Allogene Therapeutics, Inc. (ALLO)

44.96 +2.34 (5.49%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/12/20HC Wainwright & Co.MaintainsBuy49.0
6/01/20OppenheimerMaintainsOutperform55.0
6/01/20Raymond JamesDowngradesMarket Perform
5/19/20Roth CapitalUpgradesBuy60.0
5/15/20GuggenheimUpgradesBuy
5/14/20Canaccord GenuityMaintainsBuy44.0
5/14/20OppenheimerMaintainsOutperform50.0
5/14/20HC Wainwright & Co.ReiteratesBuy42.0
5/14/20SunTrust Robinson HumphreyDowngradesHold32.0
4/13/20SunTrust Robinson HumphreyInitiates Coverage OnBuy29.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter